latest updates

Press Release

Adroit Unveils Redesigned Website and New Physician Education Initiative

October 10, 2025 Company News

Adroit is pleased to announce the launch of our newly redesigned website, featuring enhanced resources for stakeholders and streamlined access to product information for our upper respiratory combination therapy.

The refreshed digital platform reflects our commitment to supporting clinicians with evidence-based tools and educational content focused on quality-of-life and optimal patient care.

What’s New

  • Product Information on Adroit’s two lead products
  • Clinical Support Tools: Interactive resources to help identify appropriate candidates for therapy
  • Enhanced Navigation: Streamlined access to contact information

Coming Soon: National Physician Outreach Initiative

  • CME Opportunities: Accredited continuing medical education programs launching in 2026
  • Streamlined access to Abuse Prevention and Control Measures (APCM) documentation

Subject to further review, Adroit will launch a comprehensive physician education initiative in 2026 centered on the question: “You Prescribe ‘Cough and Cold’ Medicine — But Is Your Patient’s Cough Really Getting Better?”

This initiative will engage healthcare providers in conversations about treatment efficacy gaps, the recent FDA proposal regarding oral phenylephrine, and evidence-based approaches to managing severe nighttime respiratory symptoms in adult patients.

Educational programming could include:

  • Clinical case studies and prescribing algorithms
  • Peer-to-peer educational forums
  • Updated clinical guidelines and best practices
“We’re committed to elevating the conversation around URTI management,” said Dr Bandyo, Chief Medical Officer at Adroit. “Our goal is to ensure healthcare providers have access to both effective treatment options and the education needed to prescribe them responsibly.”

Visit Our New Website

In the future, explore our redesigned platform at www.adroitinc.us to:

  • Read prescribing information and FDA label information
  • Learn about Risk Evaluation and Mitigation (REM) resources
  • Access educational materials and learn about upcoming events
  • Get the latest clinical data and publications

For more information about our physician education initiative or to register for upcoming CME events, please send an email to info@adroitinc.us or contact us through the website.


About Adroit
Adroit is dedicated to developing pharmaceutical solutions that address unmet medical needs in respiratory care. Our commitment to responsible innovation includes comprehensive abuse prevention measures and ongoing support for healthcare providers.

Media Contact

Anish Sankhavaram
Anish.S@adroitinc.us